Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach

Cites (328)

Items 201–323 of 323

1. Free fatty acids, insulin resistance, and type 2 diabetes mellitus
   Boden, Guenther · 1999 · Proceedings of the Association of American Physicians
2. Protein Kinase C Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation Requires Serine 612
   Kathryn De Fea, Richard A. Roth · 1997 · Biochemistry
3. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat
   Sophie Hallakou, L Doaré, Fabienne Foufelle · 1997 · Diabetes
4. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans
   Y. P. Zhou · 1995 · The Journal of Clinical Endocrinology & Metabolism
5. Circulating Tumor Necrosis Factor-α Concentrations in a Native Canadian Population with High Rates of Type 2 Diabetes Mellitus1
   Bernard Zinman, Anthony J. Hanley, Stewart B. Harris, Jeremy Kwan, I. George Fantus · 1999 · The Journal of Clinical Endocrinology & Metabolism
6. Dose-Response Effect of Pioglitazone on Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes
   Yoshinori Miyazaki, Masafumi Matsuda, Ralph Anthony DeFronzo · 2002 · Diabetes Care
7. Troglitazone prevents mitochondrial alterations, β cell destruction, and diabetes in obese prediabetic rats
   Moritake Higa, Yan-Ting Zhou, Mariella Ravazzola, Danielle Baetens, Lelio Orci, Roger H. Unger · 1999 · Proceedings of the National Academy of Sciences
8. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans
   Tom van der Poll, Johannes Anthonius Romijn, Erik Endert, Judocus J. J. Borm, Harry Roger Buller, Hans P. Sauerwein · 1991 · American Journal of Physiology-Endocrinology and Metabolism
9. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects
   Stefano Bevilacqua, Riccardo C. Bonadonna, Giuseppe Buzzigoli, Claudio De Boni, Demetrio Ciociaro, Franco Maccari, Maria Antonietta Giorico, Eleuterio Ferrannini · 1987 · Metabolism
10. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study
    Marie-Aline A Charles, É. Eschwège, Nadine Thibult, Jean‐Roger Claude, Jean‐Michel Warnet, G Rosselin, Jean R Girard, Beverley Balkau · 1997 · Diabetologia
11. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.
    André C. Carpentier, Steven D. Mittelman, Richard N. Bergman, Adria Giacca, Gary F. Lewis · 2000 · Diabetes
12. The fourth Musketeer ? from Alexandre Dumas to Claude Bernard
    Gerald M. Reaven · 1995 · Diabetologia
13. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway
    Juleen Rae Zierath, James N. Livingston, Anders Thörne, Jan Bolinder, Signy Reynisdottir, Fredrik Lönnqvist, Peter Arner · 1998 · Diabetologia
14. Control of Gluconeogenesis in Liver
    John H. Exton, Jerry G. Corbin, C R Park · 1969 · Journal of Biological Chemistry
15. Protein Kinase C-ζ Phosphorylates Insulin Receptor Substrate-1 and Impairs Its Ability to Activate Phosphatidylinositol 3-Kinase in Response to Insulin
    Lingamanaidu V. Ravichandran, Diana L. Esposito, Judy Y.‐C. Chen, Michael J. Quon · 2001 · Journal of Biological Chemistry
16. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects
    Paolisso, G., Gambardella, A., Amato, L., Tortoriello, R., D'Amore, A., Varricchio, M., D'Onofrio, F. · 1995 · Diabetologia
17. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.
    Cavaghan, M K, Ehrmann, D A, Byrne, M M, Polonsky, K S · 1997 · Journal of Clinical Investigation
18. Reconstitution of Insulin-sensitive Glucose Transport in Fibroblasts Requires Expression of Both PPARγ and C/EBPα
    Amr K. El Jack, Jonathan K. Hamm, Paul F. Pilch, Stephen R. Farmer · 1999 · Journal of Biological Chemistry
19. Humoral Regulation of Resistin Expression in 3T3-L1 and Mouse Adipose Cells
    Nobuhiro Shojima, Hideyuki Sakoda, Takehide Ogihara, Midori Fujishiro, Hideki Katagiri, Motonobu Anai, Yukiko Onishi, Hiraku Ono, Kouichi Inukai, Miho Abe et al. · 2002 · Diabetes
20. Mechanisms of the Stimulation of Insulin Release by Saturated Fatty Acids: A Study of Palmitate Effects in Mouse β-cells
    Catherine Warnotte, Patrick Gilon, Myriam Nenquin, Jean‐Claude Henquin · 1994 · Diabetes
21. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system
    Hunter, Steven J, Garvey, W.Timothy · 1998 · The American Journal of Medicine
22. Relation Between Plasma Tumor Necrosis Factor-α and Insulin Sensitivity in Elderly Men With Non–Insulin-Dependent Diabetes Mellitus
    Jan Åke Nilsson, Stefan V. Jovinge, Audrey Niemann, Richard Reneland, Hans Lithell · 1998 · Arteriosclerosis Thrombosis and Vascular Biology
23. Insulin signaling in the arterial wall
    Willa A. Hsueh, Ronald E. Law · 1999 · The American Journal of Cardiology
24. Thiazolidinediones and insulin resistance: Peroxisome proliferatoractivated receptor γ activation stimulates expression of the CAP gene
    Vered Ribon, John H. Johnson, Heidi S. Camp, Alan R. Saltiel · 1998 · Proceedings of the National Academy of Sciences
25. Human Resistin Gene: Molecular Scanning and Evaluation of Association with Insulin Sensitivity and Type 2 Diabetes in Caucasians
    Hua Wang, Winston S. Chu, Christopher Hemphill, Steven C. Elbein · 2002 · The Journal of Clinical Endocrinology & Metabolism
26. Unraveling the mechanism of action of thiazolidinediones
    C. Ronald Kahn, Lihong Chen, Shmuel E. Cohen · 2000 · Journal of Clinical Investigation
27. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans.
    Michael Roden, Martin Krššák, Harald Stingl, Susanna Gruber, Astrid Hofer, Clemens Fürnsinn, Ewald Moser, Werner K Waldhäusl · 1999 · Diabetes
28. A Promoter Genotype and Oxidative Stress Potentially Link Resistin to Human Insulin Resistance
    Steven R. Smith, Fulu Bai, Chantal Charbonneau, Lenka Rossmeislová, George A. Argyropoulos · 2003 · Diabetes
29. Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance
    Gerald M. Reaven, C.B. Hollenbeck, Y. D. I. Chen · 1989 · Diabetologia
30. Peripheral metabolic actions of leptin
    Muoio, Deborah M., Lynis Dohm, G. · 2002 · Best Practice & Research Clinical Endocrinology & Metabolism
31. Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve‐week, randomized, placebo‐controlled study
    J. Patel, R. J. Anderson, Elizabeth B. Rappaport · 1999 · Diabetes Obesity and Metabolism
32. Cell-mediated immunity in genetically obese (C57BL/6J ob/ob) mice
    Rakesh Kumar Chandra · 1980 · American Journal of Clinical Nutrition
33. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.
    JP Després, Simone Lemieux, Benoı̂t Lamarche, D. Prud homme, Sital Moorjani, Louis‐Daniel Brun, Claude Gagné, Paul J. Lupien · 1995 · PubMed
34. Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy
    Yasuhiko Iwamoto, Kinori Kosáka, Takeshi Kuzuya, Yasuo Akanuma, Yukio Shigeta, Toshio Kaneko · 1996 · Diabetes Care
35. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.
    Mason, T M, Goh, T, Tchipashvili, V, Sandhu, H, Gupta, N, Lewis, G F, Giacca, A · 1999 · Diabetes
36. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene
    Karen Reue, Ping Xu, Xu-Ping Wang, Bernard G. Slavin · 2000 · Journal of Lipid Research
37. Effects of Free Fatty Acids on Gluconeogenesis and Autoregulation of Glucose Production in Type 2 Diabetes
    Guenther H. Boden, Xinhua Chen, Edwin Capulong, Maria A. Mozzoli · 2001 · Diabetes
38. Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men
    Seppala-Lindroos, A. · 2002 · Journal of Clinical Endocrinology & Metabolism
39. Fatty Acid-Induced Insulin Resistance: Decreased Muscle PI3K Activation But Unchanged Akt Phosphorylation
    Yolanta T. Kruszynska, Dorothy Sears Worrall, Jachelle M. Ofrecio, Juan P. Frías, Gina B. Macaraeg, Jerrold M. Olefsky · 2002 · The Journal of Clinical Endocrinology & Metabolism
40. An adipocentric view of signaling and intracellular trafficking
    Sílvia Mora, Jeffrey E. Pessin · 2002 · Diabetes/Metabolism Research and Reviews
41. Inhibition by insulin of resistin gene expression in 3T3‐L1 adipocytes
    Fred Haugen, Aud Jørgensen, Christian Andre Drevon, Paul Trayhurn · 2001 · FEBS Letters
42. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.
    Ilkka Vauhkonen, LEO K. NISKANEN, Esko J. Vanninen, Sakari Kainulainen, Matti I.J. Uusitupa, Markku Laakso · 1998 · Journal of Clinical Investigation
43. A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus
    James B. Chilcott, Paul Tappenden, Myfanwy Lloyd Jones, Jeremy Wight · 2001 · Clinical Therapeutics
44. Regional differences in protein production by human adipose tissue
    Peter Arner · 2001 · Biochemical Society Transactions
45. Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients
    Y. Miyazaki, Ruben Pipek, Lawrence J. Mandarino, Ralph A. DeFronzo · 2003 · International Journal of Obesity
46. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals
    Alain Golay, Arthur Swislocki, Yii‐Der Ida Chen, Gerald M. Reaven · 1987 · Metabolism
47. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women.
    Enzo Bonora, Stefano Del Prato, Riccardo C. Bonadonna, Giovanni Gulli, Anna Solini, Myron L shank, Abraham A. Ghiatas, Jack L. Lancaster, Raphael F. Kilcoyne, Abdalmajeid M. Alyassin · 1992 · PubMed
48. Mechanisms Regulating Adipocyte Expression of Resistin
    Helen B. Hartman, Xiao Hu, Keala X. Tyler, Chiraj K. Dalal, Mitchell A. Lazar · 2002 · Journal of Biological Chemistry
49. Plasma acylation stimulating protein, adipsin and lipids in non‐obese and obese populations
    Maslowska, Vu, Phelis, Sniderman, Rhode, Blank, Cianflone · 1999 · European Journal of Clinical Investigation
50. Regional adipocity in man
    Peter Arner · 1997 · Journal of Endocrinology
51. Does Intra-Abdominal Adipose Tissue in Black Men Determine Whether NIDDM Is Insulin-Resistant or Insulin-Sensitive?
    Mary Ann Banerji, Rochelle L Chaiken, David Gordon, John G. Kral, Harold E. Lebovitz · 1995 · Diabetes
52. Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 Diabetes
    Edward S. Horton, Fred W. Whitehouse, Mahmoud N. Ghazzi, Tom C. Venable, The Troglitazone Study Group, Randall W Whitcomb · 1998 · Diabetes Care
53. Lipolysis in human adipocytes, effects of cell size, age and of regional differences.
    Peter Engfeldt, Peter Arner · 1988 · PubMed
54. Rosiglitazone Improves Downstream Insulin Receptor Signaling in Type 2 Diabetic Patients
    Yoshinori Miyazaki, Helen He, Lawrence J. Mandarino, Ralph Anthony DeFronzo · 2003 · Diabetes
55. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation
    Rolando Bacis Ceddia, WN William, Rogério Abdallah Curi · 1999 · International Journal of Obesity
56. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance.
    A. L. Thompson, G. J. Cooney · 2000 · Diabetes
57. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions
    Katherine Cianflone, Magdalena Maslowska, Allan D. Sniderman · 1999 · Seminars in Cell and Developmental Biology
58. Metabolic basis of obesity and noninsulin‐dependent diabetes mellitus
    Alain Golay, Felber Jp, Eric Jéquier, Ralph Anthony DeFronzo, Eleuterio Ferrannini · 1988 · Diabetes/Metabolism Reviews
59. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?
    Yudkin Js · 1999 · PubMed
60. Acute and Chronic Responses of Skeletal Muscle to Endurance and Sprint Exercise
    Peter J. Abernethy, Robert Thayer, Albert W. Taylor · 1990 · Sports Medicine
61. Interleukin-6 Affects Insulin Secretion and Glucose Metabolism of Rat Pancreatic Isletsin Vitro*
    Stellan Sandler, Klaus Bendtzen, Decio Laks Eizirik, Michael Welsh · 1990 · Endocrinology
62. Troglitazone but not Metformin Restores Insulin-Stimulated Phosphoinositide 3-Kinase Activity and Increases p110β Protein Levels in Skeletal Muscle of Type 2 Diabetic Subjects
    Young‐Bum Kim, Theodore P. Ciaraldi, Alice P.S. Kong, Dennis S. Kim, Neelima V. Chu, Pharis Mohideen, Sunder Raj D. Mudaliar, Robert R. Henry, Barbara B. Kahn · 2002 · Diabetes
63. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone
    Séamus Sreenan, Jeppe Sturis, W. Pugh, Charles Burant, Kenneth S. Polonsky · 1996 · American Journal of Physiology-Endocrinology and Metabolism
64. Regulation of Glucose Transport and Insulin Signaling by Troglitazone or Metformin in Adipose Tissue of Type 2 Diabetic Subjects
    Theodore P. Ciaraldi, Alice P.S. Kong, Neelima V. Chu, Dennis Dong Hwan Kim, Sunita C. Baxi, Mattias Loviscach, Raymond A Plodkowski, Richard E. Reitz, Michael P. Caulfield, Sunder Raj D. Mudaliar et al. · 2002 · Diabetes
65. Induction of Hepatic Glucose-6-Phosphatase Gene Expression by Lipid Infusion
    Duna Massillon, Nir Barzilai, Meredith A. Hawkins, Dina Prus-Wertheimer, Luciano Rossetti · 1997 · Diabetes
66. Effect of Troglitazone on Fibrinolysis and Activated Coagulation in Patients With Non–Insulin-Dependent Diabetes Mellitus
    Vivian Andrew Fonseca, Tammy Reynolds, Donna Hemphill, Carol Randolph, Jan Wall, Thomas R. Valiquett, Jane F. Graveline, Louis M. Fink · 1998 · Journal of Diabetes and its Complications
67. How obesity causes diabetes in Zucker diabetic fatty rats
    Ronald E. Unger · 1997 · Trends in Endocrinology and Metabolism
68. Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation
    Pratipanawatr, Wilailak, Pratipanawatr, Thongchai, Cusi, Kenneth, Berria, Rachele, Adams, John M., Jenkinson, Christopher P., Maezono, Katsumi, DeFronzo, Ralph A., Mandarino, Lawrence J. · 2001 · Diabetes
69. Mechanism of palmityl coenzyme A inhibition of liver glycogen synthase.
    Dhirayos Wititsuwannakul, K.H. Kim · 1977 · Journal of Biological Chemistry
70. Leptin as a Therapeutic Agent--Trials and Tribulations
    Christos Socrates Mantzoros, Jeffrey S. Flier · 2000 · The Journal of Clinical Endocrinology & Metabolism
71. Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes
    Guenther H. Boden, Peter Cheung, Maria A. Mozzoli, Susan K. Fried · 2003 · Metabolism
72. Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport
    Zeina Sfeir, Azeddine Ibrahimi, Ez‐Zoubir Amri, Paul André Grimaldi, Nada A. Abumrad · 1997 · Prostaglandins Leukotrienes and Essential Fatty Acids
73. Troglitazone Monotherapy Improves Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Randomized, Controlled Study1
    Vivian Andrew Fonseca, Thomas R. Valiquett, Saling M. Huang, Mahmoud N. Ghazzi, Randall W. Whitcomb · 1998 · The Journal of Clinical Endocrinology & Metabolism
74. Evidence Against a Direct Effect of Leptin on Glucose Transport in Skeletal Muscle and Adipocytes
    Juleen Rae Zierath, Ernst U. Frevert, Jeffrey W. Ryder, Per‐Olof Berggren, Barbara B. Kahn · 1998 · Diabetes
75. Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays.
    G Fernandes, Barry S. Handwerger, Edmond J. Yunis, David M. Brown · 1978 · Journal of Clinical Investigation
76. Effects of Acute and Chronic Exercise on Fat Metabolism
    MARTIN, WADE H. · 1996 · Exercise and Sport Sciences Reviews
77. Role of Cytokines in the Regulation of Plasminogen Activator Inhibitor-1 Expression and Secretion in Newly Differentiated Subcutaneous Human Adipocytes
    Michael Birgel, H. Gottschling-Zeller, Karin Röhrig, Hans Hauner · 2000 · Arteriosclerosis Thrombosis and Vascular Biology
78. Total Body Fat Content and Fat Topography Are Associated Differently With In Vivo Glucose Metabolism in Nonobese and Obese Nondiabetic Women
    Enzo Bonora, Stefano Del Prato, Riccardo C. Bonadonna, Giovanni Gulli, Anna Solini, Myron L shank, Abraham A. Ghiatas, Jack L. Lancaster, Raphael F. Kilcoyne, Abdalmajeid M. Alyassin et al. · 1992 · Diabetes
79. Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat
    Isabelle Hainault, Guillaume Nebout, Sophie Turban, Bernadette Ardouin, Pascal Ferré, Annie Quignard‐Boulangé · 2002 · American Journal of Physiology-Endocrinology and Metabolism
80. Subcutaneous lipectomy causes a metabolic syndrome in hamsters
    Renata V. Weber, M. C. Buckley, Susan K. Fried, John G. Kral · 2000 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
81. Angiotensinogen gene expression in 3T3-L1 cells
    Jo Anne Saye, Lisa Ann Cassis, Thomas Wayne Sturgill, Kevin R. Lynch, M J Peach · 1989 · American Journal of Physiology-Cell Physiology
82. Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes
    Toshihide Kawai, Izumi Takei, Yuko Oguma, Norimi Ohashi, Mikiya Tokui, Shuji Oguchi, Fuminori Katsukawa, Hiroshi Hirose, Akira Shimada, Kiyoaki Watanabe et al. · 1999 · Metabolism
83. Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry
    J. P. Felber, H. U. Meyer, B Curchod, Hans Ulrich Iselin, J Rousselle, E. Maeder, P. Pahud, E Jéquier · 1981 · Diabetologia
84. Effect of Troglitazone on Insulin Sensitivity and Pancreatic β-Cell Function in Women at High Risk for NIDDM
    Kathleen M. Berkowitz, Ruth K Peters, Siri L. Kjos, Jose Goico, Aura Marroquin, Meleana E. Dunn, Anny H. Xiang, Stanley P. Azen, Thomas A. Buchanan · 1996 · Diabetes
85. Regional Differences in the Response of Human Pre-Adipocytes to PPARγ and RXRα Agonists
    Ciaran P. Sewter, Fiona M. Blows, Antonio Vidal‐Puig, Stephen O’Rahilly · 2002 · Diabetes
86. Insulin Secretion in Relation to Adipose Tissue in Men
    Per A Björntorp, Peter Berchtold, Gösta Tibblin · 1971 · Diabetes
87. An allosteric model for the inhibition of glucokinase by long chain acyl coenzyme A.
    Peter S. Tippett, Kenneth Neet · 1982 · Journal of Biological Chemistry
88. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with Type II diabetes
    Giuseppe Paolisso, Maria Rosaria Tagliamonte, Maria Rosaria Rizzo, Pasquale Gualdiero, Franco Saccomanno, Antonio Gambardella, Dario Giugliano, Federica D'Onofrio, B. V. Howard · 1998 · Diabetologia
89. Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat
    S. A. Smith, Carolyn A. Lister, C. D. N. Toseland, Robin E. Buckingham · 2000 · Diabetes Obesity and Metabolism
90. Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin
    Steven D. Mittelman, Richard N. Bergman · 2000 · American Journal of Physiology-Endocrinology and Metabolism
91. Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals
    Masafumi Matsuda, Ralph Anthony DeFronzo, Leonard C. Glass, Agostino Consoli, Mauro Giordano, Peter Bressler, Stefano DelPrato · 2002 · Metabolism
92. Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus
    Werner K Waldhäusl, Paul R Bratusch-Marrain, Slobodan Gasic, A. Korn, P. Nowotny · 1982 · Diabetologia
93. Transgenic Mice Lacking White Fat: Models for Understanding Human Lipoatrophic Diabetes
    Marc L. Reitman, Mark M. Mason, Jaideep Moitra, Oksana Gavrilova, Bernice Marcus‐Samuels, Michael Eckhaus, Charles Vinson · 1999 · Annals of the New York Academy of Sciences
94. Study on lipid metabolism in obesity diabetes
    Alain Golay, J. P. Felber, H. U. Meyer, B Curchod, E. Maeder, E Jéquier · 1984 · Metabolism
95. Lack of Effect of Leptin on Glucose Transport, Lipoprotein Lipase, and Insulin Action in Adipose and Muscle Cells1
    Subramanian Ranganathan, Theodore P. Ciaraldi, Robert R. Henry, Sunder Raj D. Mudaliar, Philip A. Kern · 1998 · Endocrinology
96. Fat Distribution and Health in Obesity
    Jeanine Albu, Albert J. Kovera, Julia A. Johnson · 2000 · Annals of the New York Academy of Sciences
97. In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase
    Joseph J. Bahl, Masafumi Matsuda, Ralph A. DeFronzo, RUBIN C. BRESSLER · 1997 · Biochemical Pharmacology
98. Effect of Experimental Elevation of Free Fatty Acids on Insulin Secretion and Insulin Sensitivity in Healthy Carriers of the Pro12Ala Polymorphism of the Peroxisome Proliferator–Activated Receptor-γ2 Gene
    Norbert Stefan, Andreas Fritsche, Hans Ulrich Häring, Michael Stümvoll · 2001 · Diabetes
99. High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis
    Gavin Blake · 2001 · European Heart Journal
100. Reduced β-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding.
     K. Kaiyala, R. Prigeon, S. Kahn, S. C. Woods, D. Porte, M. Schwartz · 1999 · American Journal of Physiology. Endocrinology and Metabolism
101. Subcutaneous Abdominal Adipocyte Size, a Predictor of Type 2 Diabetes, Is Linked to Chromosome 1q21–q23 and Is Associated with a Common Polymorphism in LMNA in Pima Indians
     Christian Weyer, Johanna Kay DiStefano, Robert L. Hanson, James Edward Foley, Pietro Antonio Tataranni, Clifton Bogardus, Richard E. Pratley · 2001 · Molecular Genetics and Metabolism
102. Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer
     John L McCall, John A. Tuckey, Bryan R. Parry · 1992 · British journal of surgery
103. Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families.
     S Jackson, Stephanie M. Bagstaff, Stephen Lynn, Stephen J. Yeaman, Douglass M. Turnbull, Mark Walker · 2000 · Diabetes
104. Weight and non-insulin-dependent diabetes mellitus
     FX Pi-Sunyer · 1996 · American Journal of Clinical Nutrition
105. Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules
     Haiyan Song, Nobuhiro Shojima, Hideyuki Sakoda, Takehide Ogihara, Midori Fujishiro, Hideki Katagiri, Motonobu Anai, Yukiko Onishi, Hiraku Ono, Kouichi Inukai et al. · 2002 · Biochemical and Biophysical Research Communications
106. Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes.
     Mary Ann Stevenson, M J Zhao, Alexzander A. A. Asea, C. Norman Coleman, Stuart K. Calderwood · 1999 · PubMed
107. Inhibition of Lipolysis Decreases Lipid Oxidation and Gluconeogenesis From Lactate But Not Fasting Hyperglycemia or Total Hepatic Glucose Production in NIDDM
     I Puhakainen, Hannele Yki‐Järvinen · 1993 · Diabetes
108. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico.
     J. P. Burke, Kenneth C. Williams, S. Haffner, C. Villalpando, M. P. Stern · 2001 · Diabetes Care
109. Troglitazone inhibits angiotensin II‐induced extracellular signal‐regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells
     Stephan Goetze, Xiao-Ping Xi, Kristof Graf, Eckart Fleck, Willa A. Hsueh, Ronald E. Law · 1999 · FEBS Letters
110. Resistin: a new link between obesity and insulin resistance?
     Antonio Vidal‐Puig, Stephen O’Rahilly · 2001 · Clinical Endocrinology
111. Salicylic Acid and Aspirin Inhibit the Activity of RSK2 Kinase and Repress RSK2-Dependent Transcription of Cyclic AMP Response Element Binding Protein- and NF-κB-Responsive Genes
     Mary Ann Stevenson, Meijuan Zhao, Alexzander A. A. Asea, C. Norman Coleman, Stuart K. Calderwood · 1999 · The Journal of Immunology
112. Do Resistin and Resistin-Like Molecules Also Link Obesity to Inflammatory Diseases?
     Javier Gómez‐Ambrosi, Gema Frühbeck · 2001 · Annals of Internal Medicine
113. Familial partial lipodystrophy: Complications of obesity in the non-obese?
     David C. Robbins, Edward S. Horton, Orien L. Tulp, Ethan A.H. Sims · 1982 · Metabolism
114. Molecular biology of the β-cell ATP-sensitive K^+ channel
     Susumu Seino · 1996 · Diabetes reviews
115. Effects of altered adipose tissue morphology on plasma insulin levels in the rat
     B Schneider, Irving M. Faust, Richard B. Hemmes, J. Hirsch · 1981 · American Journal of Physiology-Endocrinology and Metabolism
116. Long-term effects of troglitazone: open-label extension studies in type 2 diabetic patients.
     Vivian Andrew Fonseca, Howard L. Foyt, Kunxue Shen, Randy Whitcomb · 2000 · Diabetes Care
117. Glucose metabolism during the menstrual cycle. Assessment with the euglycemic, hyperinsulinemic clamp.
     Michael P. Diamond, Ralph J. Jacob, Meredith Connolly-Diamond, Ralph Anthony DeFronzo · 1993 · PubMed
118. Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects
     Elisabeth Qvigstad, Ingrid Løvold Mostad, Kristian S. Bjerve, Valdemar Grill · 2003 · American Journal of Physiology-Endocrinology and Metabolism
119. Human adipose tissue expresses angiotensinogen and the enzymes required for its conversion to angiotensin II
     Lena M. S. Carlsson, Cecilia Karlsson, Kajsa Lindell, Malin Ottosson, Lars Sjöström, Björn Carlsson · 1999 · Growth Hormone & IGF Research
120. Visceral fat in relation to health: is it a major culprit or simply an innocent bystander?
     Keith N. Frayn, Jaswinder Singh Samra, Lucinda K. M. Summers · 1997 · International Journal of Obesity
121. Rosiglitazone
     Bruce H. R. Wolffenbuttel, Jean-Pierre J.E. Sels, Maya S. Huijberts · 2001 · Expert Opinion on Pharmacotherapy
122. Serum true insulin concentration and the risk of clinical non-insulin dependent diabetes during long-term follow-up
     Ivan J. Perry, S. Goya Wannamethee, Andrew Gerald Shaper, K.George M.M. Alberti · 1999 · International Journal of Epidemiology
123. Elements Regulating Cardiomyocyte Expression of the Human Sarcomeric Mitochondrial Creatine Kinase Gene in Transgenic Mice
     Wenning Qin, Zaza A. Khuchua, Steve C. Klein, Arnold W. Strauss · 1997 · Journal of Biological Chemistry